Anti-alpha-v integrin antibody for the treatment of fibrosis and/or fibrotic disorders
US-12054549-B2 · Aug 6, 2024 · US
This page is not indexed by search engines while we improve data quality.
Xu Daigen patents
Xu Daigen is listed as an inventor on 11 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Xu Daigen |
| Total patents | 11 |
| First publication | Aug 6, 2015 |
| Latest publication | Aug 6, 2024 |
Notable patents
Publications ranked by popularity score, then publication date.
Anti-alpha-v integrin antibody for the treatment of fibrosis and/or fibrotic disorders
US-2023322934-A1 · Oct 12, 2023 · US
Anti-alpha-v integrin antibody for the treatment of fibrosis and/or fibrotic disorders
US-11485786-B2 · Nov 1, 2022 · US
Anti-alpha-v integrin antibody for the treatment of fibrosis and/or fibrotic disorders
US-2020002424-A1 · Jan 2, 2020 · US
Anti-alpha-v integrin antibody for the treatment of fibrosis and/or fibrotic disorders
US-2019144547-A1 · May 16, 2019 · US
Interleukin-10 fusion proteins and uses thereof
US-10040843-B2 · Aug 7, 2018 · US
Assays for BTK inhibitors
US-10012650-B2 · Jul 3, 2018 · US
Interleukin-10 fusion proteins and uses thereof
US-2016340413-A1 · Nov 24, 2016 · US
Assays for btk inhibitors
US-2016169894-A1 · Jun 16, 2016 · US
Interleukin-10 fusion proteins
US-9346872-B2 · May 24, 2016 · US
Recent patents
Latest publications not already listed above.
Interleukin-10 fusion proteins and uses thereof
US-2015218244-A1 · Aug 6, 2015 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Merck Patent Gmbh | 7 |
| Roche Glycart Ag | 3 |
| Hoffmann La Roche | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P29/00 | 9 |
| A61P1/00 | 8 |
| A61P11/00 | 6 |
| C07K16/2848 | 5 |
| C07K2317/24 | 5 |